Primary Job Title Executive Director, Medicinal Chemistry Primary Organization 
Neuropore Therapies
Gender Male
Dr. Wrasidlo is one of the founding members of Neuropore Therapies Inc. and a research chemist with an extremely distinguished 40 plus year career in academia and the pharmaceutical industry.
Dr. Wrasidlo received a B.S. in Chemistry from San Diego State University and a Ph.D. in Organic Chemistry from the University of Erlangen and San Diego
State University.
He has held several senior level positions in academia including Director of the Chemical Biology Program at the UCSD Moores Cancer Center, UCSD School of Medicine, The Scripps Research Institute, Humboldt University Berlin Medical School, University of Tuebingen Childrens’ Hospital, and Columbia University. He has held positions in industry as a Distinguished Research Fellow at TargeGen, Inc., a Founder and the Head of Research at Brunswick Biotechnetics, a Research Scientist at General Atomics, and a member of the Member- Macromolecular Chemistry Group at the Boeing Scientific Research Institute.
Dr. Wrasidlo is a member of the American Chemical Society, the New York Academy of Science, the American Association for the Advancement of Science, the American Association for Cancer Research, and the American Society of Haematology as well as a member of the editorial board of the Journal of Pharmaceutics. He received the Kirkpatric American Chemical Society Award in Chemical Engineering, and the UCSD Connect award for the most innovative product in biotechnology R&D. He has authored over 200 scientific publications and the inventor on over 80 patents or patent applications.
